Phase II Multicenter Trial of Single Autologous Hematopoietic Cell Transplant Followed by Lenolidomide Maintenance for Multiple Myeloma with or without Vaccination with Dendritic Cell/Myeloma Fusions
|Effective start/end date||8/1/16 → 8/31/22|
- National Marrow Donor Program
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.